Clinical Trial Update: REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating reperfusion with P2Y12 inhibitors in addition to mechanical thrombectomy for perfusion-imaging-selected acute ischemic strok…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Acute Ischemia | Phase 3 | Status: RECRUITING